NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email The sweeping safety order affects more than half of the global A320 fleet and could cause operational disruptions as airlines implement software and hardware repairs.Read More